Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > A yarn about Thomas Edison and an 88 cent penny stock

<< Previous

Bullboard Posts

Next >>

Comment by settoretireon Dec 10, 2024 6:28pm

115 Views

Post# 36355612

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:A yarn about Thomas Edison and an 88 cent penny stock

Pardon me?
I'm not defending CNN, or MSNBC, but having watched the big three which includes FOX, but only two of the three tell the truth and FOX ain't one of them.
You sir, are a " fill in the blank "

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project